Mark Matson, M.D.

Rare Disease / Clinical Research

Prism Research Inc

PI on 2 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Oculocerebral hypopigmentation syndrome, Cross type
Rabies

Clinical trials (2)

NCT02040090
NCT01427257

Verify independently

ClinicalTrials.gov PI search for Mark Matson, M.D.

Other specialists for Oculocerebral hypopigmentation syndrome, Cross type

Peers ranked by clinical-trial PI role, publications, and verification quality.

Binu V John, MD MPH
Miami VA Healthcare System, Miami, FL
VA
Tomasz Masior
VectivBio AG
Muhammad Affan Iqbal, PhD*
Riphah International University
Carlos García
Fisiosesto
Tarek Elhamaky
Benha university faculty of medicine , INMC
Boehringer Ingelheim
The Institute for Liver Health II DBA Arizona Clinical Trials
Arizona
Ulrike Hövelmann, MD
Profil Institut für Stoffwechselforschung GmbH
Rémi Rabasa-Lhoret
Institut de recherches cliniques de Montréal

See all specialists for Oculocerebral hypopigmentation syndrome, Cross type →

← Back to specialists directory